Insidervault
LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM
Reporting ownerCIK 0001856078

Mark Jeffrey DeLong

26 transactions in one company, from January 13, 2026 to May 14, 2026.

Transactions
261 company
Bought · P
$0open market
Sold · S
$147Kopen market
Net
−$147Knet selling

By company

Where this insider traded.

CompanyTickerTradesBoughtSold
Apellis Pharmaceuticals, Inc.APLS26—$147K

All transactions

26 in total, newest filings first.

CompanyTickerInsiderDateCodeSharesPriceValue
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefDERIVMay 14D24,666——
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefDERIVMay 14D30,845——
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefDERIVMay 14D6,952——
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefDERIVMay 14D30,000——
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefDERIVMay 14D18,750——
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefDERIVMay 14D27,224——
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefDERIVMay 14D14,799——
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefDERIVMay 14D82,500——
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefMay 14D21,381——
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefMay 14D8,482——
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefMay 14D4,909——
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefMay 14D36,606——
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefMay 14D18,303——
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefMay 14A18,303——
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefMay 14D36,606——
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefMay 14A36,606——
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefMay 14D19,006——
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefMay 14A19,006——
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefMay 14D41,250——
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefMay 14A41,250——
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefMay 14U114,591——
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefFeb 11S368$22.15$8K
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefJan 28A36,606$0.00—
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefJan 22S3,371$21.77$73K
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefJan 20S1,334$19.79$26K
Apellis Pharmaceuticals, Inc.APLSMark Jeffrey DeLongChiefJan 13S1,780$22.19$39K